Cisco
CSCO
Alibaba
BABA
Disney
DIS
4
Apple
AAPL
5
Qualcomm
QCOM
US Stock MarketDetailed Quotes
ENTA Enanta Pharmaceuticals
- 5.860
- -0.020-0.34%
Close Mar 26 16:00 ET
- 5.860
- 0.0000.00%
Post 16:05 ET
125.01MMarket Cap-1.18P/E (TTM)
5.880High5.650Low152.56KVolume5.860Open5.880Pre Close881.07KTurnover1.07%Turnover RatioLossP/E (Static)21.33MShares17.80052wk High1.12P/B83.75MFloat Cap4.71052wk Low--Dividend TTM14.29MShs Float127.770Historical High--Div YieldTTM3.91%Amplitude4.710Historical Low5.775Avg Price1Lot Size
About Enanta Pharmaceuticals Company
Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.
Company Profile
SymbolENTA
Company NameEnanta Pharmaceuticals
Listing DateMar 21, 2013
Issue Price14.00
CEODr. Jay R. Luly, PhD
MarketNASDAQ
Employees131
Fiscal Year Ends09-30
Address4 Kingsbury Avenue
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-607-0800
Websitehttp://www.enanta.com
Company Executives
- Name
- Position
- Salary
- Dr. Jay R. Luly, PhD
- Director, President and Chief Executive Officer
- 2.70M
- Paul J. Mellett
- Chief Financial Officer, Principal Accounting Officer and Chief Administrative Officer
- 1.14M
- Brendan Luu
- Chief Business Officer
- --
- Dr. Scott T. Rottinghaus, M.D.
- Chief Medical Officer
- 1.26M
- Matthew P. Kowalsky
- Chief Legal Officer and Corporate Secretary
- --
- Dr. Yat Sun Or, PhD
- Chief Scientific Officer
- 1.22M
- Dr. Tara Lynn Kieffer, PhD
- Chief Product Strategy Officer
- --
- Dr. Bruce L.A. Carter,PhD
- Non-Executive Chairman of the Board
- 353.91K
- Kristine Peterson
- Independent Director
- 326.41K
- Mark G. Foletta
- Independent Director
- 331.41K
- Terry C. Vance
- Independent Director
- 333.91K
- Yujiro S. Hata
- Independent Director
- 318.91K
- Dr. Lesley Russell, M.R.C.P.,MB.Ch.B.
- Independent Director
- 321.41K
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings